Literature DB >> 10377166

Myocyte hypertrophy: the long and winding RhoA'd.

T Finkel1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377166      PMCID: PMC408395          DOI: 10.1172/JCI7459

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  20 in total

Review 1.  Rho GTPases and signaling networks.

Authors:  L Van Aelst; C D'Souza-Schorey
Journal:  Genes Dev       Date:  1997-09-15       Impact factor: 11.361

2.  Dissociation of p44 and p42 mitogen-activated protein kinase activation from receptor-induced hypertrophy in neonatal rat ventricular myocytes.

Authors:  G R Post; D Goldstein; D J Thuerauf; C C Glembotski; J H Brown
Journal:  J Biol Chem       Date:  1996-04-05       Impact factor: 5.157

3.  The MEKK-JNK pathway is stimulated by alpha1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy.

Authors:  M T Ramirez; V P Sah; X L Zhao; J J Hunter; K R Chien; J H Brown
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

4.  MAP kinase- and Rho-dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells.

Authors:  J Thorburn; S Xu; A Thorburn
Journal:  EMBO J       Date:  1997-04-15       Impact factor: 11.598

5.  Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle.

Authors:  K Poetter; H Jiang; S Hassanzadeh; S R Master; A Chang; M C Dalakas; I Rayment; J R Sellers; L Fananapazir; N D Epstein
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

6.  Rho is required for Galphaq and alpha1-adrenergic receptor signaling in cardiomyocytes. Dissociation of Ras and Rho pathways.

Authors:  V P Sah; M Hoshijima; K R Chien; J H Brown
Journal:  J Biol Chem       Date:  1996-12-06       Impact factor: 5.157

7.  Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure.

Authors:  J W Adams; Y Sakata; M G Davis; V P Sah; Y Wang; S B Liggett; K R Chien; J H Brown; G W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

8.  Raf-1 kinase activity is necessary and sufficient for gene expression changes but not sufficient for cellular morphology changes associated with cardiac myocyte hypertrophy.

Authors:  J Thorburn; M McMahon; A Thorburn
Journal:  J Biol Chem       Date:  1994-12-02       Impact factor: 5.157

9.  HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy.

Authors:  A Thorburn; J Thorburn; S Y Chen; S Powers; H E Shubeita; J R Feramisco; K R Chien
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

10.  Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy.

Authors:  J Thorburn; J A Frost; A Thorburn
Journal:  J Cell Biol       Date:  1994-09       Impact factor: 10.539

View more
  5 in total

1.  The rho-guanine nucleotide exchange factor domain of obscurin activates rhoA signaling in skeletal muscle.

Authors:  Diana L Ford-Speelman; Joseph A Roche; Amber L Bowman; Robert J Bloch
Journal:  Mol Biol Cell       Date:  2009-07-15       Impact factor: 4.138

2.  Essential role of obscurin in cardiac myofibrillogenesis and hypertrophic response: evidence from small interfering RNA-mediated gene silencing.

Authors:  Andrei B Borisov; Sarah B Sutter; Aikaterini Kontrogianni-Konstantopoulos; Robert J Bloch; Margaret V Westfall; Mark W Russell
Journal:  Histochem Cell Biol       Date:  2005-10-05       Impact factor: 4.304

3.  Gene dosage affects the cardiac and brain phenotype in nonmuscle myosin II-B-depleted mice.

Authors:  D Uren; H K Hwang; Y Hara; K Takeda; S Kawamoto; A N Tullio; Z X Yu; V J Ferrans; N Tresser; A Grinberg; Y A Preston; R S Adelstein
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

4.  Impact of treatment with melatonin on cerebral circulation in old rats.

Authors:  François Dupuis; Olivier Régrigny; Jeffrey Atkinson; Patrick Limiñana; Philippe Delagrange; Elizabeth Scalbert; Jean-Marc Chillon
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

5.  Obscurin, a giant sarcomeric Rho guanine nucleotide exchange factor protein involved in sarcomere assembly.

Authors:  P Young; E Ehler; M Gautel
Journal:  J Cell Biol       Date:  2001-07-09       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.